Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from ...
Eli Lilly and Company, AbbVie, Merck & Co., Inc., Pfizer, D-Wave Quantum, Johnson & Johnson, and Amgen are the seven ...
With the popular social media app once again at risk of going dark, there are best practices pharma brands can use on other ...
Tesla, Apple, Microsoft, Amazon.com, and Pfizer are the five Retail stocks to watch today, according to MarketBeat’s stock ...
Pfizer's stock has recently struggled but remains a bargain with generous dividends. Is now a good time to invest in PFE?
Zacks Investment Research on MSN6d
Pfizer Is a Dirt-Cheap High-Yield Stock, But Is It a Buy?Of late, pharmaceutical behemoth Pfizer Inc.’s PFE stock has struggled, but it remains a bargain with generous dividends. Its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback